Current Ulcerative Colitis News and Events | Page 25

Current Ulcerative Colitis News and Events, Ulcerative Colitis News Articles.
Sort By: Most Relevant | Most Viewed
Page 25 of 25 | 1000 Results
Method for direct treatment of intestinal illnesses wins prize for Hebrew University student
A method for applying drugs directly to mucousal surfaces in the intestinal system has won a coveted prize for a graduate student at the Hebrew University of Jerusalem. The method has potential for providing better treatment for such diseases as ulcerative colitis and colon cancer. (2004-06-27)

Study shows M2A capsule endoscopy improves clinical outcomes in IBD patients
Data from a study led by a researcher at Mount Sinai School of Medicine indicates that M2A capsule endoscopy --examination of the intestinal tract with the so-called (2004-05-18)

Research hones in on therapies and diagnosis of bowel diseases
Inflammatory bowel diseases collectively cause significant lifestyle sacrifices and suffering and millions of dollars in related health care costs every year, partially due to a lack of effective diagnostic procedures and therapies. In new studies presented today at Digestive Disease Week in New Orleans, researchers show evidence of accurate and effective new methods for diagnosis, as well as improved treatment options, for sufferers of ulcerative colitis and Crohn's diseases. (2004-05-18)

Cannabinoids spell relief in colon inflammation
In the current issue of The Journal of Clinical Investigation (15 April 2004) a researcher team from the Max Planck Institute of Psychiatry and from the Ludwig-Maximilans-University Munich were able to show that mutant mice lacking the cannabinoid receptor are much more prone to experimentally induced colon inflammation as compared to wild-type control mice. (2004-05-07)

Flagellation in Crohn disease
Inflammatory bowel disease (IBD) results from maladaptive immune responses to intestinal microbiota. Identifying the microbial antigens underlying IBD has been difficult. Researchers from the Dendreon Corporation determined that the dominant antigens instigating pathogenesis in Crohn's disease (CD) are from a family of novel flagellins, the major protein components of bacterial flagella. These findings underscore the link between the innate immune response and IBD pathogenesis and offer leads to the identification of other CD causal antigens. (2004-05-03)

MRI 'excellent choice' for evaluating causes of abdominal and pelvic pain in pregnant women
The accuracy and intrinsic safety of MRI in diagnosing abdominal and pelvic disease in pregnant women with acute abdominal or pelvic disease make it an excellent choice for the evaluation of these patients, a new study from researchers at the University of North Carolina Hospitals, Chapel Hill, and the University of San Diego Hospitals in California says. (2004-05-03)

U of T researchers isolate gene for Crohn's disease
Researchers at the University of Toronto have isolated a gene that predisposes people to Crohn's disease. (2004-04-11)

Diet of worms protects against bowel cancer
Regular doses of worms really do rid people of inflammatory bowel disease. The first trials of the treatment, carried out in the US, which involved a drinkable concoction of pig whipworm eggs, have been a success and the treatment could soon be available in Europe. The pig whipworm was chosen as it does not survive long in people. (2004-04-07)

Hopkins researchers find MRI useful tool in diagnosing inflammatory bowel diseases in children
Magnetic resonance imaging (MRI), coupled with the use of the contrast dye gadolinium, may help pediatricians better diagnose children with ulcerative colitis and Crohn's disease, according to a study by researchers at the Johns Hopkins Children's Center. (2004-03-04)

Majority of authors retract 1998 Lancet paper-Lancet editor points to implications
This statement refers to the Early Report (2004-03-03)

NIH researchers test promising new therapy for blinding eye disease
A clinical trial found that once monthly intravenous infusions with an immune therapy drug called daclizumab controlled uveitis and was well tolerated in seven of 10 patients over a four-year period. The study authors also found initial evidence that a furmulation of daclizumab that can be injected under the skin conferred similar results. This might allow patients to administer th drug to themselves at hom, making the treatment even more convenient. (2004-03-01)

Celiac disease is a risk factor for schizophrenia
A report published in the British Medical Journal found a link between the digestive disorder celiac disease and schizophrenia. The researchers determined that people with a history of the digestive disorder celiac disease are three times more likely to develop schizophrenia than those without the disease. Celiac disease is an autoimmune disorder that impairs the body's ability to digest the protein gluten, which is found in grains and many other foods. (2004-02-19)

Coeliac disease may predict schizophrenia
A history of coeliac disease (gluten intolerance) is a risk factor for developing schizophrenia, finds a study in this week's BMJ. (2004-02-19)

Probiotics beneficial even when inactive, according to UCSD study
Probiotics, the trendy (2004-02-02)

Bacterial DNA reduces inflammation in mice
DNA from inactivated (2004-02-02)

A pair of discoveries helps unravel complex genetics of inflammatory bowel disease
Researchers at Johns Hopkins have linked versions of two different genes with the inflammatory bowel diseases known as Crohn's disease and ulcerative colitis. The discoveries are a crucial step in developing new treatments and prevention strategies for these disabling conditions that together afflict one million Americans, the scientists say. (2003-12-19)

Protein identified that may play central role in inflammatory bowel disease
Researchers at the University of Virginia Health System have discovered that a protein expressed by the immune system, called TL1A, is linked to inflammatory bowel disease (IBD) in patients, especially Crohn's disease. This is the first time TL1A has been linked to Crohn's. (2003-11-10)

Gene mutation responsible for Chrohn's disease inflammation identified in Temple study
Temple University School of Medicine researchers have identified a genetic mutation that might be responsible for the inflammation that characterizes Crohn's disease. (2003-10-15)

Critical Therapeutics announces issuance of US patent for novel anti-inflammatory technology
Medical science's ability to block potentially lethal inflammatory proteins by stimulating a key pathway between the central nervous system and the body's major organs is the subject of an important patent announced today by Critical Therapeutics, Inc. The invention described in the patent embodies novel approaches to inhibit the cellular release of pro-inflammatory cytokines through administration of cholinergic receptor agonists or direct stimulation, including electrical stimulation of the vagus nerve. (2003-09-02)

Curcumin may be an inexpensive, well-tolerated, and effective therapy for inflammatory bowel disease
Found in mustard and other foods, curcumin may offer practical hope to two million with this debilitating disease. (2003-08-25)

Psoriasis treatment based on Weizmann Institute Research passes phase II clinical trials
Psoriasis is a chronic skin disease with as yet no cure that affects approximately 4.5 million people in the U.S. and 5.7 million people in Europe. About 10% of these people develop chronic inflammation of the joints called psoriatic arthritis. In clinical trials testing a drug based on the discovery of Prof. David Wallach of the Weizmann Institute's Biological Chemistry Department, the condition of psoriasis and psoriatic arthritis patients was greatly improved. The treatment had no adverse effects. (2003-08-11)

Study shows ulcerative colitis patients achieve remission with probiotic composition VSL#3
Researchers reported study results today that demonstrated treatment with the highly concentrated probiotic preparation, VSL#3(TM), achieved a combined induced remission and/or response rate of 86 percent in patients with active mild to moderate ulcerative colitis who were not responding to conventional therapy. (2003-05-19)

Nerve receptor found to be key to intestinal inflammation
Researchers at Duke University Medical Center have found that a specific nerve cell receptor appears to be necessary to initiate the development of inflammatory bowel disease (IBD), findings they believe could change how physicians treat this disorder. (2003-05-01)

U.Va. researcher reports on advances in treatment of a leading parasitic killer
In the developing world, one of every 10 children dies by his or her fifth birthday. In the April 17 issue of the New England Journal of Medicine, Dr. William Petri, professor of medicine at the University of Virginia Health System, discusses advances in the diagnosis and treatment of amebic dysentery, one of the leading parasitic killers of young children. (2003-04-16)

Univ of MD study on prevalence of celiac disease
A new, five-year, multi-center study finds that the autoimmune disease celiac disease is more common than previously thought, affecting one of every 133 Americans. The study, led by the University of Maryland Center for Celiac Research, looked at the prevalence of CD in both (2003-02-10)

New protein will help fight inflammation
A joint research project by scientists in Cardiff, Wales, UK, has developed a new protein, which could end the suffering of thousands. The research, at Cardiff University and the University of Wales College of Medicine (UWCM), and funded mainly by the Wellcome Trust, is designed to tackle the problem of chronic inflammation - which can lead to serious disorders such as rheumatoid arthritis and bacterial peritonitis. (2003-01-27)

Former insider hits out at FDA's links with pharmaceutical industry
A former senior consultant with the Food and Drug Administration (FDA) has criticised the American regulator's close relationship with the pharmaceutical industry. Interviewed in this week's BMJ, he attacks the FDA's decision to allow the re-marketing of a controversial drug. (2002-09-12)

Northwestern is testing experimental therapies for Crohn's disease
Researchers at the Inflammatory Bowel Disease Center at Northwestern University are conducting clinical trials of several innovative approaches to the treatment of Crohn's disease, including experimental drugs and a new swallowable video camera that produces high-quality images of the small intestine. Research related to these Crohn's disease studies appears in the Aug. 8 issue of The New England Journal of Medine. (2002-08-07)

Adults over 50 should be screened for colorectal cancer, US group says
The U.S. Preventive Services Task Force (USPSTF) recommends that all adults over 50 be screened for colorectal cancer. The recommendations and a background summary of the evidence for the recommendations are published in today's Annals of Internal Medicine. (2002-07-15)

Current colon cancer screening recommendations supported by study of 40-49 year olds
Current colon cancer screening recommendations supported by study of 40-49 year olds published by Indiana University School of Medicine researcher and colleagues in New England Journal of Medicine. (2002-06-05)

Researchers show beneficial role of bacterial DNA in fighting inflammatory bowel disease
A synthetic form of bacterial DNA, when administered to mice bred to model Inflammatory Bowel Disease (IBD), reduces the harmful effects of this serious intestinal disorder while enhancing the immune system. (2002-04-29)

Stressed intestine can give rise to food allergy
The intestines of mice which have been subjected to stress, overreact to certain nutritional substances. PhD biologist Annette van Kalkeren from the University of Amsterdam has investigated the relationship between stress and the occurrence of food allergies and various intestinal disorders. (2002-04-18)

Control of intestinal inflammation by PGE2 and its receptor
Aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) have as a common side effect the ability to damage the lining of the intestine. Since NSAIDs inhibit prostanoid biosynthesis, it is accepted that the gastric complications reflect a protective role of some prostaglandins in suppressing intestinal inflammation and damage. Still, the identity of the relevant prostaglandins has not been known, and the involvement of multiple prostaglandin receptors in this beneficial response could not be excluded. (2002-03-27)

UM researchers use 'artificial intelligence' for first time to diagnose colon tumors
Using highly sophisticated computer programs that mimic human intelligence, researchers at the University of Maryland Greenebaum Cancer Center in Baltimore have devised a new method to differentiate and diagnose several types of colon tumors.The method, which uses (2002-02-25)

Cancer-fighting drug may work in prevention and treatment
The ABCs of fighting cancer these days include two big words that describe exciting basic concepts. One is anti-angiogenesis, a strategy to stop or prevent the growth of blood vessels needed to nourish a tumor and allow it to spread. Another approach is chemoprevention--using medication to halt, delay or reverse the development of cancer. (2002-01-04)

Enzyme mimetic reduces tissue damage in colitis animal study
The estimated 1 to 2 million Americans suffering from inflammatory bowel disease may benefit from a potential new treatment, using small-molecule enzyme mimetics, based on research published in the European Journal of Pharmacology. (2001-12-12)

Hormonal changes during physiological development can alter immune response to viruses and infections
From the APS Conference (2001-10-18)

New approach to management of ulcerative colitis
Self-management of patients with ulcerative colitis could reduce health-care costs without compromising disease treatment, conclude authors of a study in this week's issue of THE LANCET. (2001-09-20)

August news briefs
Daily alcohol consumption by women whose mothers, sisters or daughters have breast cancer further increases their risk for getting the cancer, according to a Mayo Clinic study in the current issue of the journal, Cancer. A Mayo Clinic study on the use of corticosteroids to treat ulcerative colitis and Crohn's disease shows most patients don't require steroid therapy and that those who do have a poor prognosis. (2001-08-10)

Left handers at twice the risk of inflammatory bowel disease
Left handers seem to be at twice the risk of developing inflammatory bowel disease, such as Crohn's disease and ulcerative colitis, suggests research in Gut. (2001-07-11)

Page 25 of 25 | 1000 Results
   First   Previous   Next      Last is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to